期刊文献+

尿液氨基酸代谢物和血清特异生长因子联检癌症临床应用 预览 被引量:2

Clinical Application of Combined Determination of Urinary Amino Acid Metabolites and the serum of TSGF for the Diagnosis of Cancer
在线阅读 下载PDF
分享 导出
摘要 目的探讨癌症尿液筛查试剂与恶性肿瘤特异生长因子单检和联合检测癌症的临床应用.方法对153例不同部位的恶性肿瘤病人、45例非恶性肿瘤病人、150例正常人群单检和联检.结果 URC+TSGF联检阳性率除URC法单检肠癌外,其余均比单检有不同程度提高,联检与TSGF单检乳腺癌、其它癌和URC单检肝癌、肺癌、肠癌、乳腺癌、其它癌的阳性率升高有显著显著性差异(P<0.05~0.01),联检癌症总阳性率与单检总阳性率有非常显著性差异(P<0.01).结论联检对恶性肿瘤检出率明显提高,对非恶性肿瘤和正常群体筛查阳性结果能跟踪监测、相互佐证,早期发现癌变. Objective To investigate the clinical significance of URC(Urine- test Rergent for cancer screening and monitoting) and TSGF (Tumor specific Growth Factor) for the diagnosis of cancea:. Methods The combined determination was applied in 153 patients with malignant tumor, 45 patients with non - malignant disease and 150 normal controls. Results The positive rate of Combined determination of URC and TSGF was higher to different extents than one - way measuring except the URC testing/or intestinal cancer, compared with the determination of serum TSGF for mammary cancer, the other malignant tumor and the test of URC for liver cancer, lung cancer, intestinal cancer, mammary cancer and the rest malignant cancer, the positive rate of combined determination of URC and TSGF has the significant higher (P〈0.05 or P〈0.01) respectively. The total positive rate of combined determination was higher respectively than the one - way testing (P〈0.01).Conclusions The combined determination has the important significance not only for the diagnosis of malignant cancer, but also for early diagnosis and general survey to tumor.
作者 樊龙中 王昱 崔桂林 朱正洪 纪英萍 何俐勇 王平 Fan LongZhong;Wang Yu;Cui GuiLin;Zhu ZhengHong;Ji YingPing;He LiYong;Wang Ping
机构地区 广东省
出处 《实用全科医学》 2005年第5期 462-463,共2页 Applied Journal Of General Practice
  • 相关文献

参考文献3

二级参考文献13

  • 1万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:173
  • 2万文徽.肿瘤标志的研究进展及临床应用[J].《全国肿瘤标志研究进展及临床应用研讨班教材》,2002,11:9-15. 被引量:1
  • 3陈名声 刘建新 于文彬 等.血清组织多肽特异性抗原水平与肺癌生物学行为的关系[J].中华结核和呼吸杂志,2002,25:262-264. 被引量:1
  • 4Furuya N, Kawa S, Tokoo M, et al. Comparative study of CA242 and CA19-9 in chronic pancreatitis. Br J cancer, 1996,73:372-376. 被引量:1
  • 5Hahn U, Schumann T, Schietke I, et al. Decrease of CA19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer, 2000,82:1013-1016. 被引量:1
  • 6Kulpa J, Wojcik E, Radkowski A, et al. CYFRA 21-1, TPA-M,TPS, SCC-Ag and CEA in patients with squamous ceil lung cancer and in chemical industry workers as a reference group. Anticancer Res,2000,20:5035-5040. 被引量:1
  • 7Sun KS, Hsieh,JF, Tsai SC, et al. Tissue Polypeptide-Specific Antigen and Carcinoembryonic Antigen for Early Prediction of Recurrence in Lung Adenocarcinoma. Am J Clin Oncol,2000,23:605-608. 被引量:1
  • 8Nisman B,Lafair J,Heching N,et al. Evaluation of tissue polypeptide specific antigen, CYFRA21-1 and carcinoembryonic antigen in nonsmall cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information? Cancer, 1998,82 : 1850-1859. 被引量:1
  • 9Ho YJ,Hsieh JF,Tasi SC,et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma. Lung,2000,178:75-80. 被引量:1
  • 10Pina TC,Zapata IT,Lopez JB,et al. Tumor marker in lung cancer:does the method of obtaining the cut-off point and reference population influence diagnostic yield? Clin biochem, 1999,32 : 467-472. 被引量:1

共引文献150

同被引文献28

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈